LOGIN  |  REGISTER
Terns Pharmaceuticals

DBV Technologies: Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

October 05, 2023 | Last Trade: US$10.83 0.16 -1.46

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

(Article 223-16 of the General Regulations of the Autorité des Marchés Financiers)

Market : NYSE Euronext Paris
ISIN Code: FR 0010417345

 

Date

 
Total number of shares Total number of voting rights
09/30/2023

 
96,253,553

 
 

Total gross of voting rights: 96,253,553

 
 

Total net* of voting rights: 96,076,898

 

* Net total = total number of voting rights attached to shares – shares without voting rights = 96,253,553 – 176,655 = 96,076,898

Chimerix

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Immix Biopharma

Immix Biopharma is a clinical-stage biopharmaceutical company pioneering a novel class of CAR-T cell therapies and Tissue-Specific Therapeutics targeting oncology and immuno-dysregulated diseases with >75 patients treated to-date. Our lead cell therapy asset is NXC-201...

CLICK TO LEARN MORE

End of content

No more pages to load

Next page